
Keywords: Alzheimer's disease; Fragile X syndrome; Glycogen synthase kinase-3; Learning; Lithium; LTPAD, Alzheimer's disease; Aβ, amyloid-β peptide; APP, amyloid precursor protein; CNS, central nervous system; FX, Fragile X; GSK3, glycogen synthase kinase-3; LTD, l